SYGNIS Reports Financial Results For The Second Quarter And First Six Months Of 2017 Post author:Sam Post published:August 2, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like InstantLabs Secures Controlling Investment From February 23, 2017 Jazz Pharma Announces Offering Of $500 Million Of 1.50% Exchangeable Senior Notes Due 2024 August 17, 2017 Why Boston-Bound Alexion Could be a Compelling M&A for Larger Drugmakers January 29, 2018
Jazz Pharma Announces Offering Of $500 Million Of 1.50% Exchangeable Senior Notes Due 2024 August 17, 2017